See how top analysts and institutions rate STLA — including buy, hold, and sell recommendations.
| Rating Source | Action | Rating | Target Price | Updated |
|---|---|---|---|---|
| Berenberg | Upgrade | Hold → Buy | $11.20 | 2025-09-19 |
| BNP Paribas Exane | Resumed | Neutral | $10.10 | 2025-09-08 |
| BofA Securities | Downgrade | Buy → Neutral | $11.75 | 2025-07-07 |
| Wolfe Research | Downgrade | Peer Perform → Underperform | 2025-07-02 | |
| Jefferies | Upgrade | Hold → Buy | $13.20 | 2025-06-25 |
| Date | Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|---|
| November 2025 | 2 | 1 | 5 | 0 | 0 |
| October 2025 | 2 | 1 | 5 | 0 | 0 |
| September 2025 | 2 | 1 | 5 | 0 | 0 |
| August 2025 | 2 | 1 | 5 | 0 | 0 |
The majority of institutional investors have issued a "Buy" rating for STLA, and analyst sentiment aligns closely, with very few "Sell" recommendations. This suggests a broadly favorable outlook for the stock's performance.
